Impact of coordination and monitoring of care by telemonitoring on the quality of care provided to users with chronic diseases of the Unified Health System discharged from the hospital in Belo Horizonte, MG, Brazil: randomized clinical study

Not Applicable

• Conditions: Diabetes Mellitus; Chronic Obstructive Pulmonary Disease; Congestive Heart Failure

• Registration Number: RBR-10znr9xn
• Lead Sponsor: Faculdade de Medicina da Universidade Federal de Minas Gerais

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-01
• Study Completion: 2021-12-27
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients willing and able to complete the study requirements, including signing the Informed Consent Form. Patients discharged due to Congestive heart failure, Chronic obstructive pulmonary disease and diabetes mellitus requesting insulin. Patients residing in Belo Horizonte, Minas Gerais. Adult patients over 18 years old.

Exclusion Criteria

Pregnant or breastfeeding patients. Patients with Chronic Kidney Disease on dialysis. Cancer patients undergoing chemotherapy. Patients with diseases that reduce survival to less than six months. Patients undergoing bariatric surgery. Patients using depot corticotherapy daily use or expected use for more than fourteen days in the next six months. Patients undergoing enteral nutritional therapy. Patients unable to interview or to operate telemonitoring devices. Complete illiterate patients. Patients with severe motor and cognitive neurological sequelae. Patients with recent blood loss, severe anemia, hereditary anemia or use of blood transfusion. Patients in whom the diagnosis of exacerbated COPD has not been confirmed, having been replaced by other differential diagnoses such as left ventricular failure, pulmonary thromboembolism. Patients with clinical indication for oxygen home therapy without access to oxygen. Patients with acute myocardial infarction less than 72 hours, unstable angina less than 72 hours after stabilization. Patients with symptomatic severe valvular heart disease with surgical indication. Patients with uncontrolled arterial hypertension: SBP greater than 190mmHg and DBP greater than 120mmHg. Patients with decompensated heart failure, severe complex ventricular arrhythmias, suspected instability or severe left coronary artery injury, infective endocarditis, myocarditis or pericarditis, type A aortic dissection or acute type B phase and severe symptomatic obstruction of the ventricular outflow tract left with low effort-induced output. Patients with orthopedic or neurological conditions that overlap the respiratory condition and that limit physical activity. Patients who have acute causes of heart failure in the past 30 days, such as acute coronary syndrome, cardiac surgery or invasive procedures, implantation of devices. Patients with invasive cardiac procedures scheduled for the three months following the enrollment of participants. Patients in line for heart transplantation or with an implanted ventricular assist device. Patients with a condition that may limit compliance with study procedures such as known alcohol and drug abuse. Patients participating in other intervention studies.

Study & Design

• Study Type: Intervention
• Study Design: Not specified